J L Jouve

Prognostic factors after curative resection for gastric cancer. A population-based study

S. Msika, A M Benhamiche, J L Jouve et al. · European Journal of Cancer · 2000 · 123 citations

Medicine, Oncology, Surgery +14

Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)

Thomas Aparicio, Sandrine Lavau‐Denès, Jean–Marc Phelip et al. · Annals of Oncology · 2015 · 111 citations · Full text

Medicine, Oncology, Pharmacology +8

Idarubicin‐loaded beads for chemoembolisation of hepatocellular carcinoma: results of the<scp>IDASPHERE</scp>phase I trial

Mathieu Boulin, Patrick Hillon, Jean–Pierre Cercueil et al. · Alimentary Pharmacology & Therapeutics · 2014 · 60 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Management and prognosis of esophageal cancers: Has progress been made?

Anne‐Marie Bouvier, Christine Binquet, A. Gagnaire et al. · European Journal of Cancer · 2005 · 53 citations

Medicine, Oncology, Surgery +14

Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening

J L Jouve, Laurent Remontet, Vincent Dancourt et al. · British Journal of Cancer · 2001 · 39 citations · Full text

Medicine, Oncology, Preventive Medicine +17